Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kremil-S is an over-the-counter (OTC) gastrointestinal combination product developed and marketed by United International Pharma, primarily in Vietnam. It is formulated to provide symptomatic relief for various acid-related and gas-related gastrointestinal disorders. The product typically contains a combination of aluminum hydroxide and magnesium hydroxide, which serve as antacids by neutralizing gastric hydrochloric acid, and simethicone, an anti-foaming agent that reduces the surface tension of gas bubbles to alleviate bloating and flatulence. Kremil-S is indicated for conditions such as gastric and duodenal ulcers, gastritis, esophagitis, heartburn, acid reflux, and indigestion. It is available in multiple oral delivery formats including chewable tablets and liquid gel suspensions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kremil-S.